NL-OMON28903已完成不适用
A phase I/ II study.<br>Efficacy and safety of alpha / betaT- /CD19B-cell depleted allogeneic haematopoietic stem cells transplantation in high risk or relapsed acute leukaemia / MDS followed by an innate donor lymphocyte infusion (iDLI).
MC UtrechtHeidelberglaan 1003584 CX Utrecht0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Age 18-65 years;
- •2. Meeting the criteria for a allo-SCT and high risk disease * (see below);
排除标准
- •1. Relapse of allo-SCT within 6 months after allo-SCT;
- •2. Relapse acute promyelocyten leukemia;
研究者
相似试验
已完成
不适用
A study to detect the effect of radiofrequent ablation in combination with ipilimumab in patients with eye melanoma that spread out to the liver.uveal melanomaliver metastasesoog melanoomlever metastasenNL-OMON26122KI-AV44
已完成
2 期
A phase I/ II study;Efficacy and safety of alpha / beta T- /CD19B-cell depleted allogeneic haematopoietic stem cells transplantation in high risk or relapsed acute leukaemia / MDS followed by an innate donor lymphocyte infusion (iDLI)leukemia bloodcancer10024324NL-OMON35919niversitair Medisch Centrum Utrecht30
撤回
2 期
A phase I/ II study ;Efficacy and safety of alpha/ beta T- /CD19B-cell depleted allogeneic haematopoietic stem cells transplantation in high risk or relapsed acute leukaemia / MDS followed by an innate donor lymphocyte infusion (iDLI)leukemia bloodcancer10024324NL-OMON34123niversitair Medisch Centrum Utrecht30
招募中
1 期
The Study of Safety and Preliminary Efficacy of Aleeto in Patients With MultIple System AtrophyMultiple System Atrophy - Parkinsonian Subtype (MSA-P)Multiple System Atrophy, MSANCT06765733Beijing Tiantan Hospital20
尚未招募
1 期
Safety and Preliminary Efficacy of Aleeto in Amyotrophic Lateral SclerosisAmyotrophic Lateral SclerosisNCT06181526Beijing Tiantan Hospital24